Does Wegovy Increase Libido — and What Might Actually Be Going On?

You've noticed something changing, and you're wondering whether it's the medicine

It's a question our prescribers hear. You've been on Wegovy for a few months, you've lost a meaningful amount of weight, and something else has shifted too, perhaps your energy, your mood, or your interest in sex. It can feel strange to connect those dots, and even stranger to ask about it. That instinct to wonder is completely reasonable.

The honest starting point is this: semaglutide does not work on the hormones or brain circuits that regulate sexual desire. The NHS medicines page for semaglutide lists its recognised side effects (gastrointestinal symptoms lead the list) and changes in libido are not among them. So if something has shifted for you, the medicine itself is almost certainly not the direct cause.

What is a direct cause, in both directions, is weight. Obesity is independently associated with lower testosterone in men and disrupted oestrogen balance in women. It also tends to raise levels of sex hormone-binding globulin, which mops up the hormones that are circulating. Add in the fatigue and low mood that often accompany excess weight, and the result is a cluster of factors that together suppress sexual interest. Lose a significant amount of weight, and several of those factors begin to reverse, not because of any specific medicine, but because of what weight loss does to the body's hormonal environment.

What weight loss studies actually found about sexual function

Researchers have been interested in this area for years, separately from the GLP-1 story. Studies in people who lost substantial weight through bariatric surgery, caloric restriction, or other means have consistently found improvements in self-reported sexual function, particularly in men whose testosterone rose as their BMI fell. The relationship is real, it just belongs to weight loss as a process, not to any single treatment.

The STEP 1 trial (the pivotal 68-week semaglutide 2.4 mg study published in the New England Journal of Medicine) reported an average body-weight reduction of around 15% in people without diabetes. That scale of change is large enough to plausibly shift hormone levels in the direction described above. The trial did not measure libido or sexual function, so there is no direct data to quote, only the reasonable inference that some participants likely experienced the same hormonal knock-on effects seen in earlier weight-loss research.

There is also the energy and self-image dimension. Fatigue is one of the more underappreciated consequences of carrying significant excess weight. As people lose weight on Wegovy, many report feeling physically lighter and less exhausted in their daily lives, and some will be approaching or reaching the 2.0 mg dose by the point those changes become most noticeable. None of this is a guaranteed outcome, and a prescriber is the right person to explore it with you properly.

If you are at the stage of considering whether to start or continue treatment, our Wegovy overview covers what the evidence shows about how the medicine works.

When libido goes the other way, a less-discussed possibility

Some people report the opposite: that their interest in sex has dropped since starting Wegovy. This is worth taking seriously rather than dismissing. There are a few plausible reasons. GI side effects (nausea in particular) are common in the first weeks at a new dose, and it is very hard to feel interested in anything when you feel sick. Those symptoms typically ease as the body adjusts, but during that window they can genuinely flatten mood and desire.

There is also a broader psychological dimension. Changing how you eat, how you feel, and how you see yourself is not a neutral experience. Some people find the transition disorientating, even when the weight loss is welcome. If you are finding that your mood or mental wellbeing has shifted in a way that concerns you, that conversation belongs with your prescriber, not in a forum thread.

Our page on whether Wegovy can decrease libido goes into more detail on the factors that can pull in that direction. Understanding the titration schedule matters here too: dose increases are a common trigger for a fresh round of GI symptoms, and how dose increases work is worth reading before your next step up.

What to do if libido changes are a concern for you

Changes to sexual interest (up or down) are not a reason to stop treatment without speaking to a prescriber first. The right first question is whether other causes are in play: sleep quality, relationship stress, other medicines, thyroid function, and mood disorders are all more common explanations than the medicine itself.

If you want a fuller picture of the dose schedule and where you are in the titration journey, the Wegovy dose increase chart lays out the typical progression. For a broader look at how treatment evolves over time, the evidence on higher doses and outcomes puts the titration question in context. And if you are still working out which treatment might suit you, the weight-loss treatment overview covers the options licensed for adults in the UK.

One final point: semaglutide is a prescription-only medicine, and any prescriber worth their registration will tell you that questions about how your body is responding (including this one) are exactly what clinical follow-up is for. At nume, every repeat order goes back in front of a real clinician before it is dispensed. If something has changed for you, that is the place to say so.

If you would like to explore whether Wegovy is clinically appropriate for you, check your eligibility with a free consultation, reviewed the same day by a GPhC-registered prescriber.